You probably have heard about outpatient therapies relying on medications such as ivermectin pills and monoclonal antibodies infusions. But have you heard about povidone iodine
In this second part of our webinar, Dr Tyson and Dr Fareed engage into a discussion of how to deal with age when treating very
This article looks at the coverage of COVID-19 by Dr Mehmet Cengiz Öz, from courageous reporting on early treatment at the beginning of the pandemic,
Geert Vanden Bossche, DMV, PhD, an independent virologist and vaccine expert from Belgium, formerly employed at the Vaccine Alliance GAVI and at The Bill &
Professor Harvey Risch responded today to a post by Sebastian Rushworth M.D., a physician in Stockholm, Sweden, who maintains a popular blog on C19. The
Considering the burden on hospitals, the decision was made to treat the asymptomatic and mild cases at home and moderate and severe cases in the hospitals.
“We live in a strange post-truth world devoid of honest free speech, integrity, compassion & science.” — Professor Robert Clancy Selected Highlights both early treatment
“Between both of us now, we are close to 5000 positive patients we have seen and treated. Our death rate is 2 out of those
This February 20, the IHU Marseille had as distinguished guest for a video conference: the prestigious Stanford Professor, John P.A. Ioannidis, MD, PhD The theme
This 30 min interview reviews the whereabouts of C19 treatments since the beginning of the pandemic, both at US and global levels, with emphasis on
Learn about the best practices for treating older people, at home or in nursing homes, drawing from the practical experience of two of the very
The results of the so called STOIC clinical trial run by Oxford University and testing budesonide have just been published as a pre-print on medrxiv.